Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients.

Vera TiedjeSaskia TingRobert Fred WalterThomas HeroldKarl WormJulia BadziongDenise ZwanzigerKurt Werner SchmidDagmar Fuhrer

Published in: European journal of endocrinology (2016)

In this study, we identified molecular markers in primary tumour tissue of sporadic MTC associated with the development of metastasis (both lymph node and organ metastasis) as well as response to vandetanib therapy.

Keyphrases

lymph node
late onset
amyotrophic lateral sclerosis
neoadjuvant chemotherapy
squamous cell carcinoma
bone marrow
early onset
sentinel lymph node
mesenchymal stem cells
cell therapy
single molecule
smoking cessation